APA (7th ed.) Citation

MH, S., WF, M., O, C., SK, B., FD, A., W, S., . . . MA, W. (2010). The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up. American journal of hematology, 85(6), 403. https://doi.org/10.1002/ajh.21699

Chicago Style (17th ed.) Citation

MH, Steinberg, et al. "The Risks and Benefits of Long-term Use of Hydroxyurea in Sickle Cell Anemia: A 17.5 Year Follow-up." American Journal of Hematology 85, no. 6 (2010): 403. https://doi.org/10.1002/ajh.21699.

MLA (9th ed.) Citation

MH, Steinberg, et al. "The Risks and Benefits of Long-term Use of Hydroxyurea in Sickle Cell Anemia: A 17.5 Year Follow-up." American Journal of Hematology, vol. 85, no. 6, 2010, p. 403, https://doi.org/10.1002/ajh.21699.